Bastide Le Confort Médical SA
Bastide Le Confort Médical SA, together with its subsidiaries, engages in the sale and rental of medical equipment in France, the United Kingdom, Belgium, Spain, Canada, the Netherlands, and Italy. It operates in six segments: Respiratory Assistance, Home Care, Healthcare Facilities, Nutrition/Infusion/Diabetes, Stoma Therapy/Urology/Wound Care, and E-commerce. The company offers reclining chairs… Read more
Bastide Le Confort Médical SA (BLC) - Net Assets
Latest net assets as of June 2025: €71.30 Million EUR
Based on the latest financial reports, Bastide Le Confort Médical SA (BLC) has net assets worth €71.30 Million EUR as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€661.03 Million) and total liabilities (€589.73 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €71.30 Million |
| % of Total Assets | 10.79% |
| Annual Growth Rate | 4.15% |
| 5-Year Change | -16.18% |
| 10-Year Change | 20.4% |
| Growth Volatility | 7.1 |
Bastide Le Confort Médical SA - Net Assets Trend (2008–2025)
This chart illustrates how Bastide Le Confort Médical SA's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Bastide Le Confort Médical SA (2008–2025)
The table below shows the annual net assets of Bastide Le Confort Médical SA from 2008 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | €71.30 Million | -11.68% |
| 2024-06-30 | €80.72 Million | -8.36% |
| 2023-06-30 | €88.09 Million | +1.65% |
| 2022-06-30 | €86.66 Million | +1.89% |
| 2021-06-30 | €85.06 Million | +6.83% |
| 2020-06-30 | €79.62 Million | +19.84% |
| 2019-06-30 | €66.44 Million | -4.03% |
| 2018-06-30 | €69.23 Million | +10.68% |
| 2017-06-30 | €62.55 Million | +5.62% |
| 2016-06-30 | €59.22 Million | +8.76% |
| 2015-06-30 | €54.45 Million | +8.21% |
| 2014-06-30 | €50.32 Million | +8.23% |
| 2013-06-30 | €46.49 Million | +7.40% |
| 2012-06-30 | €43.29 Million | +4.90% |
| 2011-06-30 | €41.27 Million | +5.21% |
| 2010-06-30 | €39.23 Million | +6.66% |
| 2009-06-30 | €36.78 Million | +3.01% |
| 2008-06-30 | €35.71 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Bastide Le Confort Médical SA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 155.8% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €59.31 Million | 82.22% |
| Common Stock | €3.36 Million | 4.66% |
| Other Components | €9.46 Million | 13.12% |
| Total Equity | €72.13 Million | 100.00% |
Bastide Le Confort Médical SA Competitors by Market Cap
The table below lists competitors of Bastide Le Confort Médical SA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Kewal Kiran Clothing Limited
NSE:KKCL
|
$81.12 Million |
|
Summit Midstream Corporation
NYSE:SMC
|
$81.12 Million |
|
Cemindo Gemilang Tbk PT
JK:CMNT
|
$81.15 Million |
|
INVICTA HLDGS RC-05
F:I5J
|
$81.18 Million |
|
Elektrotim SA
WAR:ELT
|
$81.11 Million |
|
F3 Uranium Corp.
OTCQB:FUUFF
|
$81.10 Million |
|
Emerging Display Technologies Corp
TW:3038
|
$81.09 Million |
|
Eliem Therapeutics Inc
NASDAQ:ELYM
|
$81.07 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Bastide Le Confort Médical SA's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 79,772,000 to 72,132,000, a change of -7,640,000 (-9.6%).
- Net income of 528,000 contributed positively to equity growth.
- Dividend payments of 569,000 reduced retained earnings.
- Share repurchases of 4,000 reduced equity.
- Other factors decreased equity by 7,595,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €528.00K | +0.73% |
| Dividends Paid | €569.00K | -0.79% |
| Share Repurchases | €4.00K | -0.01% |
| Other Changes | €-7.59 Million | -10.53% |
| Total Change | €- | -9.58% |
Book Value vs Market Value Analysis
This analysis compares Bastide Le Confort Médical SA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.64x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 4.93x to 2.64x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2008-06-30 | €4.86 | €24.00 | x |
| 2009-06-30 | €5.01 | €24.00 | x |
| 2010-06-30 | €5.34 | €24.00 | x |
| 2011-06-30 | €5.59 | €24.00 | x |
| 2012-06-30 | €5.88 | €24.00 | x |
| 2013-06-30 | €6.32 | €24.00 | x |
| 2014-06-30 | €6.84 | €24.00 | x |
| 2015-06-30 | €7.31 | €24.00 | x |
| 2016-06-30 | €8.01 | €24.00 | x |
| 2017-06-30 | €8.45 | €24.00 | x |
| 2018-06-30 | €9.10 | €24.00 | x |
| 2019-06-30 | €8.66 | €24.00 | x |
| 2020-06-30 | €10.29 | €24.00 | x |
| 2021-06-30 | €11.05 | €24.00 | x |
| 2022-06-30 | €11.47 | €24.00 | x |
| 2023-06-30 | €11.04 | €24.00 | x |
| 2024-06-30 | €10.69 | €24.00 | x |
| 2025-06-30 | €9.09 | €24.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Bastide Le Confort Médical SA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.73%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.11%
- • Asset Turnover: 0.74x
- • Equity Multiplier: 9.16x
- Recent ROE (0.73%) is below the historical average (9.88%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | 16.49% | 6.21% | 1.29x | 2.06x | €2.32 Million |
| 2009 | 6.10% | 2.32% | 1.22x | 2.16x | €-1.43 Million |
| 2010 | 7.28% | 2.86% | 1.20x | 2.13x | €-1.07 Million |
| 2011 | 7.79% | 2.93% | 1.13x | 2.35x | €-904.80K |
| 2012 | 8.15% | 2.85% | 1.19x | 2.41x | €-800.20K |
| 2013 | 8.91% | 3.08% | 1.17x | 2.48x | €-505.90K |
| 2014 | 10.18% | 3.36% | 1.11x | 2.73x | €92.70K |
| 2015 | 12.68% | 3.97% | 1.07x | 2.98x | €1.44 Million |
| 2016 | 12.23% | 3.74% | 1.02x | 3.21x | €1.31 Million |
| 2017 | 8.76% | 2.49% | 0.85x | 4.16x | €-767.20K |
| 2018 | 10.73% | 2.48% | 0.75x | 5.76x | €489.40K |
| 2019 | 7.20% | 1.36% | 0.85x | 6.24x | €-1.78 Million |
| 2020 | 15.33% | 3.03% | 0.76x | 6.69x | €4.03 Million |
| 2021 | 16.54% | 3.03% | 0.78x | 7.00x | €5.32 Million |
| 2022 | 16.18% | 2.92% | 0.74x | 7.48x | €5.22 Million |
| 2023 | 13.74% | 2.37% | 0.77x | 7.50x | €3.28 Million |
| 2024 | -1.13% | -0.17% | 0.82x | 8.11x | €-8.88 Million |
| 2025 | 0.73% | 0.11% | 0.74x | 9.16x | €-6.69 Million |
Industry Comparison
This section compares Bastide Le Confort Médical SA's net assets metrics with peer companies in the Medical Distribution industry.
Industry Context
- Industry: Medical Distribution
- Average net assets among peers: $17,355,372
- Average return on equity (ROE) among peers: -8.54%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Bastide Le Confort Médical SA (BLC) | €71.30 Million | 16.49% | 8.27x | $81.11 Million |
| Euromedis Groupe SA (ALEMG) | $34.88 Million | -17.07% | 0.72x | $4.87 Million |
| Metrics in Balance NV (MLMIB) | $-170.25K | 0.00% | 0.00x | $311.84 |